Sep 28, 2026 06:30AM
Mar 1, 2026 07:00PM
Dec 25, 2025 03:45AM
Jun 4, 2025 08:00PM
May 31, 2025 09:39PM
Apr 23, 2025 07:00PM
Mar 18, 2025 08:57PM Innovent and HUTCHMED Say FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Met Primary Endpoint
Mar 18, 2025 08:55PM
Mar 2, 2025 07:00PM
Dec 15, 2024 06:57PM
Dec 15, 2024 06:55PM
Jun 13, 2024 08:32PM
May 9, 2023 08:00PM
May 7, 2023 08:00PM Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer
Jun 26, 2022 08:00PM
Jun 12, 2022 09:33PM
Jun 12, 2022 08:00PM
Jun 5, 2022 08:00PM
Aug 5, 2021 08:00PM
May 16, 2021 09:00PM
Nov 4, 2020 07:00PM Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020

68,529 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All